NCT02754206

Brief Summary

The purpose of this study is to understand how biochemical markers in blood, balance disturbances, and cognitive performance are related to brain blood flow changes after a concussion.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 20, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 28, 2016

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

September 14, 2021

Status Verified

September 1, 2021

Enrollment Period

5.7 years

First QC Date

April 20, 2016

Last Update Submit

September 7, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cerebral blood flow regulation

    Subject's cerebral blood flow regulation (cm/sec) at rest, during a cognitive test, and during a breathing test will be measured.

    Change in Control, 3 days post concussion, 21 days post concussion, and 3 months post concussion

Secondary Outcomes (5)

  • Blood Biomarkers

    Control, 3 days post concussion, 21 days post concussion, 3 months post concussion

  • Memory Function Test

    Control, 3 days post concussion, 21 days post concussion, 3 months post concussion

  • Balance Test

    Control, 3 days post concussion, 21 days post concussion, 3 months post concussion

  • Orthostatic Tolerance Test

    Control, 3 days post concussion, 21 days post concussion, 3 months post concussion

  • Cerebral Vasoreactivity

    Control, 3 days post concussion, 21 days post concussion, 3 months post concussion

Study Arms (2)

Control

Subjects who are collegiate level athletes who do not have a concussion and are currently playing a contact-collision sport.

Concussed

Subjects who have recently suffered a sports-related concussion and are currently a collegiate athlete playing a contact-collision sport.

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Collegiate Athletes who are currently playing a contact-collision sport.

You may qualify if:

  • Student athletes actively participating in collegiate sports. Subjects should be wiling to provide informed consent for participation in the study.

You may not qualify if:

  • Participants who are unable to play as a result of injury. Presence of irregular heart beat.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Southern Methodist University

Dallas, Texas, 75205, United States

Location

Related Publications (1)

  • Purkayastha S, Adair H, Woodruff A, Ryan LJ, Williams B, James E, Bell KR. Balance Testing Following Concussion: Postural Sway versus Complexity Index. PM R. 2019 Nov;11(11):1184-1192. doi: 10.1002/pmrj.12129. Epub 2019 Apr 3.

MeSH Terms

Conditions

Brain ConcussionPost-Concussion Syndrome

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, Nonpenetrating

Study Officials

  • Sushmita Purkayastha, Ph.D

    Southern Methodist University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Research Compliance

Study Record Dates

First Submitted

April 20, 2016

First Posted

April 28, 2016

Study Start

January 1, 2016

Primary Completion

September 1, 2021

Study Completion

September 1, 2021

Last Updated

September 14, 2021

Record last verified: 2021-09

Locations